Speech from Rogier Janssens, Managing Director and General Manager of Merck’s biopharma business in China
Caption Speech from Rogier Janssens, Managing Director and General Manager of Merck’s biopharma business in China
Source Merck
Other pictures
Download
Related Press Releases Links Merck Announces Collaboration with Xian Janssen to Launch INVOKANA(R) (canagliflozin) for the Treatment of Type 2 Diabetes in China
默克宣布与西安杨森合作在中国推出2型糖尿病治疗新型药物怡可安